Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	IgG receptor activity	FCGR2C FCGR2A FCGR2B	1.42e-05	7	150	3	GO:0019770
GeneOntologyMolecularFunction	IgG binding	FCGR2C FCGR2A FCGR2B	6.56e-05	11	150	3	GO:0019864
GeneOntologyMolecularFunction	cytoskeletal protein binding	ROCK2 CTTNBP2 MYLK MID2 CAPN2 ESPNL NUMA1 MYO18A LMTK2 RUSC1 DPYSL4 C10orf90 AGBL5 CEP350 MRTFB TTLL4 NAV3 MYO18B CAMSAP1 GOLGA8A HTT	7.54e-05	1099	150	21	GO:0008092
GeneOntologyMolecularFunction	immunoglobulin receptor activity	FCGR2C FCGR2A FCGR2B	1.42e-04	14	150	3	GO:0019763
GeneOntologyMolecularFunction	low-affinity IgG receptor activity	FCGR2A FCGR2B	3.33e-04	4	150	2	GO:0019772
GeneOntologyMolecularFunction	immunoglobulin receptor binding	FCGR2A IGHG2 IGHG4	5.00e-04	21	150	3	GO:0034987
GeneOntologyMolecularFunction	small GTPase binding	ROCK2 CDC42EP4 ERC1 EXPH5 RHOBTB3 RUSC2 RPTOR HPS4 FGD5	7.34e-04	321	150	9	GO:0031267
GeneOntologyBiologicalProcess	antibody-dependent cellular cytotoxicity	FCGR2C FCGR2A FCGR2B IGHG2 IGHG4	2.34e-08	13	150	5	GO:0001788
GeneOntologyBiologicalProcess	type IIa hypersensitivity	FCGR2C FCGR2A FCGR2B IGHG2 IGHG4	5.39e-08	15	150	5	GO:0001794
GeneOntologyBiologicalProcess	type II hypersensitivity	FCGR2C FCGR2A FCGR2B IGHG2 IGHG4	5.39e-08	15	150	5	GO:0002445
GeneOntologyBiologicalProcess	regulation of type I hypersensitivity	FCGR2A FCGR2B IGHG2 IGHG4	3.29e-07	9	150	4	GO:0001810
GeneOntologyBiologicalProcess	type I hypersensitivity	FCGR2A FCGR2B IGHG2 IGHG4	5.45e-07	10	150	4	GO:0016068
GeneOntologyBiologicalProcess	regulation of type IIa hypersensitivity	FCGR2A FCGR2B IGHG2 IGHG4	8.52e-07	11	150	4	GO:0001796
GeneOntologyBiologicalProcess	regulation of type II hypersensitivity	FCGR2A FCGR2B IGHG2 IGHG4	8.52e-07	11	150	4	GO:0002892
GeneOntologyBiologicalProcess	hypersensitivity	FCGR2C FCGR2A FCGR2B IGHG2 IGHG4	8.99e-07	25	150	5	GO:0002524
GeneOntologyBiologicalProcess	regulation of hypersensitivity	FCGR2A FCGR2B IGHG2 IGHG4	9.57e-06	19	150	4	GO:0002883
GeneOntologyBiologicalProcess	acute inflammatory response to antigenic stimulus	FCGR2C FCGR2A FCGR2B IGHG2 IGHG4	1.30e-05	42	150	5	GO:0002438
GeneOntologyBiologicalProcess	positive regulation of type I hypersensitivity	FCGR2A IGHG2 IGHG4	2.06e-05	8	150	3	GO:0001812
GeneOntologyBiologicalProcess	regulation of B cell mediated immunity	FCGR2A FCGR2B IGHG2 IGHG4 TP53BP1 IL27RA	2.40e-05	79	150	6	GO:0002712
GeneOntologyBiologicalProcess	regulation of immunoglobulin mediated immune response	FCGR2A FCGR2B IGHG2 IGHG4 TP53BP1 IL27RA	2.40e-05	79	150	6	GO:0002889
GeneOntologyBiologicalProcess	regulation of acute inflammatory response to antigenic stimulus	FCGR2A FCGR2B IGHG2 IGHG4	4.14e-05	27	150	4	GO:0002864
GeneOntologyBiologicalProcess	positive regulation of type IIa hypersensitivity	FCGR2A IGHG2 IGHG4	4.36e-05	10	150	3	GO:0001798
GeneOntologyBiologicalProcess	positive regulation of type II hypersensitivity	FCGR2A IGHG2 IGHG4	4.36e-05	10	150	3	GO:0002894
GeneOntologyBiologicalProcess	negative regulation of type I hypersensitivity	FCGR2A FCGR2B	5.25e-05	2	150	2	GO:0001811
GeneOntologyBiologicalProcess	immunoglobulin mediated immune response	TREX1 FCGR2C FCGR2A FCGR2B IGHG2 IGHG4 C7 TP53BP1 IL27RA	5.72e-05	235	150	9	GO:0016064
GeneOntologyBiologicalProcess	protein localization to microtubule cytoskeleton	MCPH1 MID2 NUMA1 CEP350 HTT	6.94e-05	59	150	5	GO:0072698
GeneOntologyBiologicalProcess	B cell mediated immunity	TREX1 FCGR2C FCGR2A FCGR2B IGHG2 IGHG4 C7 TP53BP1 IL27RA	7.64e-05	244	150	9	GO:0019724
GeneOntologyBiologicalProcess	positive regulation of phagocytosis	MYO18A FCGR2C FCGR2A FCGR2B IGHG2 IGHG4	8.60e-05	99	150	6	GO:0050766
GeneOntologyBiologicalProcess	humoral immune response mediated by circulating immunoglobulin	FCGR2A FCGR2B IGHG2 IGHG4 C7	8.82e-05	62	150	5	GO:0002455
GeneOntologyBiologicalProcess	protein localization to cytoskeleton	MCPH1 MID2 NUMA1 CEP350 HTT	9.52e-05	63	150	5	GO:0044380
GeneOntologyBiologicalProcess	inflammatory response to antigenic stimulus	TREX1 FCGR2C FCGR2A FCGR2B IGHG2 IGHG4	1.07e-04	103	150	6	GO:0002437
GeneOntologyBiologicalProcess	positive regulation of hypersensitivity	FCGR2A IGHG2 IGHG4	1.61e-04	15	150	3	GO:0002885
GeneOntologyBiologicalProcess	protein localization to microtubule organizing center	MCPH1 NUMA1 CEP350 HTT	1.81e-04	39	150	4	GO:1905508
GeneOntologyBiologicalProcess	regulation of B cell activation	FCGR2A FCGR2B IGHG2 IGHG4 PRLR TP53BP1 IL27RA	1.93e-04	163	150	7	GO:0050864
GeneOntologyBiologicalProcess	positive regulation of acute inflammatory response to antigenic stimulus	FCGR2A IGHG2 IGHG4	2.38e-04	17	150	3	GO:0002866
GeneOntologyBiologicalProcess	phagocytosis, recognition	MYO18A FCGR2A IGHG2 IGHG4	2.43e-04	42	150	4	GO:0006910
GeneOntologyBiologicalProcess	establishment of mitotic spindle localization	MCPH1 NUMA1 ESPL1 HTT	2.91e-04	44	150	4	GO:0040001
GeneOntologyBiologicalProcess	negative regulation of hypersensitivity	FCGR2A FCGR2B	3.12e-04	4	150	2	GO:0002884
GeneOntologyBiologicalProcess	immunoglobulin production	TREX1 FCGR2A FCGR2B IGHG2 IGHG4 TP53BP1 IL7R IL27RA	3.92e-04	241	150	8	GO:0002377
GeneOntologyBiologicalProcess	early endosome to late endosome transport	LMTK2 PIK3R4 IGHG2 IGHG4	4.77e-04	50	150	4	GO:0045022
GeneOntologyBiologicalProcess	regulation of phagocytosis	MYO18A FCGR2C FCGR2A FCGR2B IGHG2 IGHG4	4.84e-04	136	150	6	GO:0050764
GeneOntologyBiologicalProcess	mitotic cell cycle process	ROCK2 EXOC6 TREX1 MCPH1 NUMA1 C10orf90 KANK2 L3MBTL1 FBXO5 HECW2 RPTOR EXOC6B ANKRD17 ESPL1 GOLGA8A HTT	5.00e-04	854	150	16	GO:1903047
GeneOntologyBiologicalProcess	regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway	FCGR2A FCGR2B	5.18e-04	5	150	2	GO:1903381
GeneOntologyBiologicalProcess	negative regulation of neutrophil apoptotic process	FCGR2A FCGR2B	5.18e-04	5	150	2	GO:0033030
GeneOntologyBiologicalProcess	endosomal transport	ERC1 RHOBTB3 LMTK2 PIK3R4 FCGR2A FCGR2B IGHG2 IGHG4 HTT	5.71e-04	320	150	9	GO:0016197
GeneOntologyBiologicalProcess	Golgi ribbon formation	MYO18A GORASP1 GOLGA8A	6.00e-04	23	150	3	GO:0090161
GeneOntologyBiologicalProcess	positive regulation of inflammatory response to antigenic stimulus	FCGR2A IGHG2 IGHG4	6.00e-04	23	150	3	GO:0002863
GeneOntologyBiologicalProcess	regulation of immunoglobulin production	TREX1 FCGR2A FCGR2B TP53BP1 IL27RA	6.52e-04	95	150	5	GO:0002637
GeneOntologyBiologicalProcess	positive regulation of B cell mediated immunity	FCGR2A IGHG2 IGHG4 TP53BP1	7.36e-04	56	150	4	GO:0002714
GeneOntologyBiologicalProcess	vesicle-mediated transport between endosomal compartments	LMTK2 PIK3R4 IGHG2 IGHG4	7.36e-04	56	150	4	GO:0098927
GeneOntologyBiologicalProcess	positive regulation of immunoglobulin mediated immune response	FCGR2A IGHG2 IGHG4 TP53BP1	7.36e-04	56	150	4	GO:0002891
GeneOntologyBiologicalProcess	neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	FCGR2A FCGR2B	7.73e-04	6	150	2	GO:0036483
MousePheno	maximal tonic hindlimb extension seizures	SZT2 FCGR2A FCGR2B	1.24e-05	6	121	3	MP:0002194
MousePheno	increased susceptibility to type I hypersensitivity reaction	EXPH5 FCGR2A FCGR2B IGHG2 IGHG4	3.31e-05	43	121	5	MP:0005596
MousePheno	abnormal B cell number	ASXL1 TREX1 CTTNBP2 MCPH1 SH2D3C GPATCH2 BCL11A GFI1 FCGR2A FCGR2B IGHG2 IGHG4 ZNF335 TP53BP1 IL7R	4.81e-05	526	121	15	MP:0002458
Domain	fn3	IGFN1 LRFN1 MYLK DSCAM MID2 PRLR IL7R IL27RA	4.33e-05	162	147	8	PF00041
Domain	Sec15	EXOC6 EXOC6B	6.15e-05	2	147	2	PF04091
Domain	EXOC6/Sec15	EXOC6 EXOC6B	6.15e-05	2	147	2	IPR007225
Domain	FN3	IGFN1 LRFN1 MYLK DSCAM MID2 PRLR IL7R IL27RA	1.82e-04	199	147	8	PS50853
Domain	HARE-HTH	ASXL1 ASXL3	1.84e-04	3	147	2	PF05066
Domain	ASXH	ASXL1 ASXL3	1.84e-04	3	147	2	PF13919
Domain	PHD_3	ASXL1 ASXL3	1.84e-04	3	147	2	PF13922
Domain	ASX-like_PHD	ASXL1 ASXL3	1.84e-04	3	147	2	IPR026905
Domain	ASXH	ASXL1 ASXL3	1.84e-04	3	147	2	IPR028020
Domain	ASX/ASX-like	ASXL1 ASXL3	1.84e-04	3	147	2	IPR024811
Domain	HB1/Asxl_HTH	ASXL1 ASXL3	1.84e-04	3	147	2	IPR007759
Domain	FN3_dom	IGFN1 LRFN1 MYLK DSCAM MID2 PRLR IL7R IL27RA	2.54e-04	209	147	8	IPR003961
Domain	Ig-like_fold	IGFN1 LRFN1 MYLK DSCAM MID2 UNC5B FCGR2A FCGR2B IGHG2 IGHG4 ALPK3 PRLR PLXNB1 IL7R IL27RA	4.60e-04	706	147	15	IPR013783
Domain	IGc2	IGFN1 LRFN1 MYLK DSCAM UNC5B FCGR2A FCGR2B ALPK3	5.55e-04	235	147	8	SM00408
Domain	Ig_sub2	IGFN1 LRFN1 MYLK DSCAM UNC5B FCGR2A FCGR2B ALPK3	5.55e-04	235	147	8	IPR003598
Domain	FN3	IGFN1 LRFN1 MYLK DSCAM MID2 PRLR IL27RA	6.63e-04	185	147	7	SM00060
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SZT2 RHOBTB3 LMTK2 NACAD PASK SF3B3 ZNF608 HECW2 RPTOR HPS4 TTLL4 ANKIB1 ANKRD17 SCAF11 FAM149B1 ESPL1 CFAP97 PLXNB1	3.87e-11	529	157	18	14621295
Pubmed	IgG2a-mediated enhancement of antibody and T cell responses and its relation to inhibitory and activating Fc gamma receptors.	FCGR2A FCGR2B IGHG2 IGHG4	1.38e-08	7	157	4	15100265
Pubmed	IgG-mediated enhancement of antibody responses is low in Fc receptor gamma chain-deficient mice and increased in Fc gamma RII-deficient mice.	FCGR2A FCGR2B IGHG2 IGHG4	1.38e-08	7	157	4	10395649
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	STIM2 CDC42EP4 ERC1 EXPH5 KIAA0232 LMTK2 CBARP ERBIN RUSC2 CEP350 PIK3R4 ARFGEF3 FAM171A2 RPTOR ANKRD17 BRD1 CAMSAP1 CFAP97 CCSER1	1.41e-08	861	157	19	36931259
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ROCK2 LRFN1 CTTNBP2 DSCAM ERC1 NUMA1 DPYSL4 TSC1 BCL11A KANK2 ERBIN FAM171A2 RPTOR ANKRD17 QSER1 FRMPD3 CAMSAP1 PPP6R2 GOLGA8A TP53BP1	1.56e-08	963	157	20	28671696
Pubmed	Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1.	FCGR2A FCGR2B IGHG2 IGHG4	4.95e-08	9	157	4	22922409
Pubmed	Inhibitory Fcγ receptor is required for the maintenance of tolerance through distinct mechanisms.	FCGR2A FCGR2B IGHG2 IGHG4	4.95e-08	9	157	4	24563255
Pubmed	Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice.	FCGR2A FCGR2B IGHG2 IGHG4	4.95e-08	9	157	4	8552190
Pubmed	Basophil-mediated protection against gastrointestinal helminths requires IgE-induced cytokine secretion.	FCGR2A FCGR2B IGHG2 IGHG4	4.95e-08	9	157	4	25404305
Pubmed	Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice.	FCGR2A FCGR2B IGHG2 IGHG4	8.22e-08	10	157	4	8769481
Pubmed	Nonallelic homologous recombination of the FCGR2/3 locus results in copy number variation and novel chimeric FCGR2 genes with aberrant functional expression.	FCGR2C FCGR2A FCGR2B	9.02e-08	3	157	3	26133275
Pubmed	Functional Fcgamma receptor polymorphisms are associated with human allergy.	FCGR2C FCGR2A FCGR2B	9.02e-08	3	157	3	24586589
Pubmed	Calcium-induced tripartite binding of intrinsically disordered calpastatin to its cognate enzyme, calpain.	CAPN2 CAPNS1 CAST	9.02e-08	3	157	3	18519038
Pubmed	Calpain system protein expression and activity in ovarian cancer.	CAPN2 CAPNS1 CAST	9.02e-08	3	157	3	30448882
Pubmed	FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.	FCGR2A FCGR2B IGHG2 IGHG4	1.29e-07	11	157	4	11911824
Pubmed	Involvement of a tissue-specific autoantibody in skin disorders of murine systemic lupus erythematosus and autoinflammatory diseases.	FCGR2A FCGR2B IGHG2 IGHG4	1.29e-07	11	157	4	16492738
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	PRKD2 DUSP7 GPATCH2 RTN3 POLR2M MON1A KANK2 ERBIN RUSC2 CEP350 PIK3R4 ANKRD13A PASK MRTFB GORASP1 RPTOR TTLL4 ESPL1 PPP6R2	2.57e-07	1038	157	19	26673895
Pubmed	SZT2 maintains hematopoietic stem cell homeostasis via nutrient-mediated mTORC1 regulation.	SZT2 TSC1 RPTOR	3.60e-07	4	157	3	36250465
Pubmed	Activation of Calpain-2 by Mediators in Pulmonary Vascular Remodeling of Pulmonary Arterial Hypertension.	CAPN2 CAPNS1 CAST	3.60e-07	4	157	3	26248159
Pubmed	FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia.	FCGR2A IGHG2 IGHG4	8.97e-07	5	157	3	9834201
Pubmed	Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B.	FCGR2C FCGR2A FCGR2B	8.97e-07	5	157	3	19309690
Pubmed	Serine-threonine kinase ROCK2 regulates germinal center B cell positioning and cholesterol biosynthesis.	ROCK2 IGHG2 IGHG4	8.97e-07	5	157	3	32229726
Pubmed	SNPs of Fc-gamma receptor genes and chronic periodontitis.	FCGR2C FCGR2A FCGR2B	8.97e-07	5	157	3	20439936
Pubmed	Copy number, linkage disequilibrium and disease association in the FCGR locus.	FCGR2C FCGR2A FCGR2B	8.97e-07	5	157	3	20508037
Pubmed	Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16).	FCGR2A IGHG2 IGHG4	8.97e-07	5	157	3	9743367
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	KCNH8 MCPH1 MID2 KIAA0232 CAST GPATCH2 RTN3 ADGRL1 TEP1 ERBIN ITGB5 ARFGEF3 MRTFB ZNF608 RPTOR EXOC6B ANKIB1 SLX4IP ANKRD17 SCAF11 QSER1 HTT	1.03e-06	1489	157	22	28611215
Pubmed	B Cell-Intrinsic mTORC1 Promotes Germinal Center-Defining Transcription Factor Gene Expression, Somatic Hypermutation, and Memory B Cell Generation in Humoral Immunity.	IGHG2 IGHG4 RPTOR	1.79e-06	6	157	3	29531165
Pubmed	Association of the calpain/calpastatin network with subcellular organelles.	CAPN2 CAPNS1 CAST	1.79e-06	6	157	3	14559243
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	ROCK2 STIM2 CDC42EP4 EXPH5 UNC5B TSC1 CBARP ERBIN FAM171A2 CRACDL CAMSAP1 KDF1 PLXNB1	2.09e-06	569	157	13	30639242
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ERC1 RTN3 TSC1 ARFGEF3 MRTFB SF3B3 BRF1 RPTOR PPP4R2 TOPORS PPP6R2 TOP3A TP53BP1	2.98e-06	588	157	13	38580884
Pubmed	A family of protein-deglutamylating enzymes associated with neurodegeneration.	MYLK AGBL5 TTLL4	3.12e-06	7	157	3	21074048
Pubmed	IgG1 is pathogenic in Leishmania mexicana infection.	FCGR2A IGHG2 IGHG4	4.97e-06	8	157	3	21037092
Pubmed	Altered gene expression for calpain/calpastatin system in motor neuron degeneration (Mnd) mutant mouse brain and spinal cord.	CAPN2 CAPNS1 CAST	4.97e-06	8	157	3	9473662
Pubmed	IL-7/anti-IL-7 mAb complexes augment cytokine potency in mice through association with IgG-Fc and by competition with IL-7R.	FCGR2A FCGR2B IL7R	4.97e-06	8	157	3	23610371
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	ERC1 KANK2 ERBIN CEP350 ARFGEF3 PASK FAM193A CAMSAP1	5.28e-06	209	157	8	36779422
Pubmed	Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ROCK2 ADAMTS4 EXPH5 L3MBTL1 ANKRD17 PPP6R2	7.24e-06	102	157	6	9734811
Pubmed	FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo.	FCGR2A IGHG2 IGHG4	7.43e-06	9	157	3	20974962
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	SZT2 CAPNS1 CRPPA GFI1 ARFGEF3 FAM193A L3MBTL1 ASXL3 ZNF335 FSHB FGD5 MUC20	8.60e-06	552	157	12	10737800
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ASXL1 ERC1 KIAA0232 ERBIN CEP68 PASK MRTFB ZNF608	9.05e-06	225	157	8	12168954
Pubmed	Development of Th1-type immune responses requires the type I cytokine receptor TCCR.	IGHG2 IGHG4 IL27RA	1.45e-05	11	157	3	11057672
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	STIM2 ERC1 CAPN2 MYO18A LMTK2 RTN3 ADGRL1 CBARP ERBIN NACAD ARFGEF3 FAM171A2 RPTOR NAV3 CAMSAP1 PPP6R2 TP53BP1	1.68e-05	1139	157	17	36417873
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ASXL1 ERC1 KIAA0232 ADGRL1 TSC1 BCL11A ERBIN RUSC2 ARFGEF3 NAV3	1.76e-05	407	157	10	12693553
Pubmed	Vital role of the calpain-calpastatin system for placental-integrity-dependent embryonic survival.	CAPN2 CAPNS1 CAST	1.93e-05	12	157	3	21791606
Pubmed	IL-7Rα glutamylation and activation of transcription factor Sall3 promote group 3 ILC development.	AGBL5 TTLL4 IL7R	1.93e-05	12	157	3	28794449
Pubmed	Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection.	FCGR2A FCGR2B	2.02e-05	2	157	2	23616574
Pubmed	FcgammaRIIa (CD32) polymorphism and anti-malarial IgG subclass pattern among Fulani and sympatric ethnic groups living in eastern Sudan.	FCGR2A FCGR2B	2.02e-05	2	157	2	19284648
Pubmed	Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunity.	FCGR2A FCGR2B	2.02e-05	2	157	2	17548594
Pubmed	Intraperitoneal Immunization with Cry1Ac Protoxin from Bacillus thuringiensis Provokes Upregulation of Fc-Gamma-II/and Fc-Gamma-III Receptors Associated with IgG in the Intestinal Epithelium of Mice.	FCGR2A FCGR2B	2.02e-05	2	157	2	25904149
Pubmed	Development of self-reactive germinal center B cells and plasma cells in autoimmune Fc gammaRIIB-deficient mice.	FCGR2A FCGR2B	2.02e-05	2	157	2	21078890
Pubmed	FcγRIIB is a T cell checkpoint in antitumor immunity.	FCGR2A FCGR2B	2.02e-05	2	157	2	33616086
Pubmed	Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb-/- lupus model.	FCGR2A FCGR2B	2.02e-05	2	157	2	33861790
Pubmed	FcgammaRIIb inhibits allergic lung inflammation in a murine model of allergic asthma.	FCGR2A FCGR2B	2.02e-05	2	157	2	20179765
Pubmed	Respiratory syncytial virus persistence in macrophages upregulates Fcgamma receptors expression.	FCGR2A FCGR2B	2.02e-05	2	157	2	24509813
Pubmed	Antigen-Specific IgG ameliorates allergic airway inflammation via Fcγ receptor IIB on dendritic cells.	FCGR2A FCGR2B	2.02e-05	2	157	2	21477339
Pubmed	Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia.	FCGR2A FCGR2B	2.02e-05	2	157	2	32684632
Pubmed	Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis.	FCGR2A FCGR2B	2.02e-05	2	157	2	11983693
Pubmed	Acute Kidney Injury Induced Lupus Exacerbation Through the Enhanced Neutrophil Extracellular Traps (and Apoptosis) in Fcgr2b Deficient Lupus Mice With Renal Ischemia Reperfusion Injury.	FCGR2A FCGR2B	2.02e-05	2	157	2	34248948
Pubmed	Negative regulation of c-kit-mediated cell proliferation by Fc gamma RIIB.	FCGR2A FCGR2B	2.02e-05	2	157	2	10201978
Pubmed	Antigen-induced oligomerization of the B cell receptor is an early target of Fc gamma RIIB inhibition.	FCGR2A FCGR2B	2.02e-05	2	157	2	20083655
Pubmed	Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium.	FCGR2C FCGR2B	2.02e-05	2	157	2	2531080
Pubmed	Genomic organization of mouse Fc gamma receptor genes.	FCGR2A FCGR2B	2.02e-05	2	157	2	2138787
Pubmed	Fc receptors: rubor redux.	FCGR2A FCGR2B	2.02e-05	2	157	2	8069908
Pubmed	Genetic control of T-cell proliferative response in mice linked to chromosomes 11 and 15.	FCGR2A FCGR2B	2.02e-05	2	157	2	8824160
Pubmed	Regulation of allograft survival by inhibitory FcγRIIb signaling.	FCGR2A FCGR2B	2.02e-05	2	157	2	23150718
Pubmed	FcγRIIIA Negatively Impacts Humoral Immune Responses but Not Overall Lung Inflammation in an Ovalbumin-Induced Allergic Asthma Mouse Model.	FCGR2A FCGR2B	2.02e-05	2	157	2	29597194
Pubmed	Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.	FCGR2A FCGR2B	2.02e-05	2	157	2	21357255
Pubmed	Association of FcγRIIB and FcγRIIA R131H gene polymorphisms with renal involvement in Egyptian systemic lupus erythematosus patients.	FCGR2A FCGR2B	2.02e-05	2	157	2	24366619
Pubmed	Differences in endocytosis mediated by FcγRIIA and FcγRIIB2.	FCGR2A FCGR2B	2.02e-05	2	157	2	21945020
Pubmed	Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody.	FCGR2A FCGR2B	2.02e-05	2	157	2	16925577
Pubmed	FcγRIIb on liver sinusoidal endothelium clears small immune complexes.	FCGR2A FCGR2B	2.02e-05	2	157	2	23053513
Pubmed	A complementary DNA clone for a macrophage-lymphocyte Fc receptor.	FCGR2A FCGR2B	2.02e-05	2	157	2	3024012
Pubmed	Human rhinovirus type 2-antibody complexes enter and infect cells via Fc-gamma receptor IIB1.	FCGR2A FCGR2B	2.02e-05	2	157	2	14990693
Pubmed	Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease.	FCGR2A FCGR2B	2.02e-05	2	157	2	10704470
Pubmed	Affinity purification of human m-calpain through an intrinsically disordered inhibitor, calpastatin.	CAPN2 CAPNS1	2.02e-05	2	157	2	28319173
Pubmed	Biochemical characterization of murine lymphoid alloantigen Ly-m20.2, a cell surface marker controlled by a gene linked to the Mls locus.	FCGR2A FCGR2B	2.02e-05	2	157	2	3161943
Pubmed	Lipopolysaccharide Impedes Bone Repair in FcγRIIB-Deficient Mice.	FCGR2A FCGR2B	2.02e-05	2	157	2	38069267
Pubmed	Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII.	FCGR2A FCGR2B	2.02e-05	2	157	2	10704418
Pubmed	Plasmodium curtails autoimmune nephritis via lasting bone marrow alterations, independent of hemozoin accumulation.	FCGR2A FCGR2B	2.02e-05	2	157	2	37539049
Pubmed	Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies.	FCGR2A FCGR2B	2.02e-05	2	157	2	23897982
Pubmed	CD32B, the human inhibitory Fc-gamma receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma.	FCGR2A FCGR2B	2.02e-05	2	157	2	16757681
Pubmed	FcγRIIb attenuates TLR4‑mediated NF‑κB signaling in B cells.	FCGR2A FCGR2B	2.02e-05	2	157	2	28849025
Pubmed	Fc receptor beta chain deficiency exacerbates murine arthritis in the anti-type II collagen antibody-induced experimental model.	FCGR2A FCGR2B	2.02e-05	2	157	2	23053716
Pubmed	Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells.	FCGR2A FCGR2B	2.02e-05	2	157	2	15843524
Pubmed	Lupus nephritis progression in FcγRIIB-/-yaa mice is associated with early development of glomerular electron dense deposits and loss of renal DNase I in severe disease.	FCGR2A FCGR2B	2.02e-05	2	157	2	29190833
Pubmed	Identification of a high affinity FcgammaRIIA-binding peptide that distinguishes FcgammaRIIA from FcgammaRIIB and exploits FcgammaRIIA-mediated phagocytosis and degradation.	FCGR2A FCGR2B	2.02e-05	2	157	2	18957413
Pubmed	Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice.	FCGR2A FCGR2B	2.02e-05	2	157	2	19644866
Pubmed	Comment on "The inhibiting Fc receptor for IgG, FcgammaRIIB, is a modifier of autoimmune susceptibility".	FCGR2A FCGR2B	2.02e-05	2	157	2	21969314
Pubmed	Immunoglobulin E plays an immunoregulatory role in lupus.	FCGR2A FCGR2B	2.02e-05	2	157	2	25267791
Pubmed	FcγRIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis.	FCGR2A FCGR2B	2.02e-05	2	157	2	24869670
Pubmed	Lupus-Associated Immune Complexes Activate Human Neutrophils in an FcγRIIA-Dependent but TLR-Independent Response.	FCGR2A FCGR2B	2.02e-05	2	157	2	30610165
Pubmed	Fc receptors.	FCGR2A FCGR2B	2.02e-05	2	157	2	1910686
Pubmed	Susceptibility quantitative trait loci for pathogenic leucocytosis in SCG/Kj mice, a spontaneously occurring crescentic glomerulonephritis and vasculitis model.	FCGR2A FCGR2B	2.02e-05	2	157	2	24654803
Pubmed	An alloantigen selective for B cells: Ly-17.1.	FCGR2A FCGR2B	2.02e-05	2	157	2	6974691
Pubmed	Functional Role of FcγRIIB in the Regulation of Mesenchymal Stem Cell Function.	FCGR2A FCGR2B	2.02e-05	2	157	2	26941575
Pubmed	Differential role of three major New Zealand Black-derived loci linked with Yaa-induced murine lupus nephritis.	FCGR2A FCGR2B	2.02e-05	2	157	2	15634937
Pubmed	Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus.	FCGR2A FCGR2B	2.02e-05	2	157	2	10508186
Pubmed	Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.	FCGR2A FCGR2B	2.02e-05	2	157	2	26451966
Pubmed	Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes.	FCGR2A FCGR2B	2.02e-05	2	157	2	17142741
Pubmed	Activatory and inhibitory Fcγ receptors augment rituximab-mediated internalization of CD20 independent of signaling via the cytoplasmic domain.	FCGR2A FCGR2B	2.02e-05	2	157	2	25568316
Pubmed	A lupus-suppressor BALB/c locus restricts IgG2 autoantibodies without altering intrinsic B cell-tolerance mechanisms.	FCGR2A FCGR2B	2.02e-05	2	157	2	18322187
Interaction	YWHAG interactions	STIM2 ERC1 EXPH5 KIAA0232 CAPNS1 SH2D3C LMTK2 RTN3 TSC1 CBARP ERBIN RUSC2 CEP350 PIK3R4 SF3B3 FAM171A2 RPTOR SPRYD3 ANKRD17 SCAF11 BRD1 CAMSAP1 PRLR CFAP97 IL7R HTT CCSER1	7.36e-07	1248	153	27	int:YWHAG
Interaction	YWHAZ interactions	PRKD2 ASXL1 STIM2 ERC1 EXPH5 KIAA0232 CAPNS1 SH2D3C MYO18A TSC1 CBARP KANK2 ERBIN RUSC2 FAM171A2 ASXL3 RPTOR SPRYD3 ANKRD17 SCAF11 PRR14L BRD1 CAMSAP1 PRLR TP53BP1 HTT CCSER1	2.12e-06	1319	153	27	int:YWHAZ
Interaction	YWHAH interactions	PRKD2 STIM2 CDC42EP4 ERC1 EXPH5 KIAA0232 CAPNS1 LMTK2 TSC1 CBARP ERBIN RUSC2 CEP350 PIK3R4 ARFGEF3 FAM171A2 RPTOR SPRYD3 ANKRD17 BRD1 CAMSAP1 CFAP97 HTT CCSER1	2.96e-06	1102	153	24	int:YWHAH
GeneFamily	Fibronectin type III domain containing	IGFN1 LRFN1 MYLK DSCAM MID2 IL7R IL27RA	1.62e-05	160	91	7	555
GeneFamily	Myosins, class XVIII	MYO18A MYO18B	2.51e-05	2	91	2	1107
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	IGFN1 LRFN1 MYLK DSCAM UNC5B ALPK3	1.62e-04	161	91	6	593
GeneFamily	Exocyst complex	EXOC6 EXOC6B	8.82e-04	9	91	2	1055
GeneFamily	PDZ domain containing	MYO18A ERBIN GORASP1 FRMPD2B FRMPD3	1.02e-03	152	91	5	1220
GeneFamily	Ankyrin repeat domain containing	CTTNBP2 ESPNL KANK2 ANKRD13A ANKIB1 ANKRD17	1.40e-03	242	91	6	403
GeneFamily	BPI fold containing	BPIFB1 BPIFA2	2.87e-03	16	91	2	456
Coexpression	GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	ATP5MC2 PRKD2 RMND5B TREX1 SF3B3 ZNF608 CRACDL KDF1 TP53BP1	3.50e-06	200	157	9	M309
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	STIM2 IGFN1 KCNH8 DSCAM RUSC1 ADGRL1 BCL11A INSYN2A RUSC2 ARFGEF3 BRF1 CSRNP3 ASXL3 NAV3 ANKIB1 FRMPD3 BRD1 GOLGA8A PRLR CCSER1	1.08e-05	1106	157	20	M39071
Coexpression	GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN	MYLK RUBCNL KANK2 GFI1 NTAN1 FBXO5 HPS4 ESPL1	2.24e-05	193	157	8	M6903
Coexpression	GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP	PRKD2 AVPR2 KANK2 PIK3R4 PASK MRTFB GOLGA8A PHTF1	2.89e-05	200	157	8	M3404
Coexpression	GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	MYLK EXPH5 TSC1 KANK2 CEP68 MRTFB FBXO5 ZNF608	2.89e-05	200	157	8	M7518
Coexpression	WENDT_COHESIN_TARGETS_UP	EXOC6 CAST POLR2M GOLGA8A	3.91e-05	32	157	4	M10024
CoexpressionAtlas	dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_1000	EXOC6 PRKD2 STIM2 MID2 UNC5B SH2D3C MYO18A POLR2M INSYN2A MRTFB HECW2 NAV3 FGD5 CCSER1	1.83e-05	523	148	14	gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k4_1000
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EXOC6 STIM2 ERC1 SH2D3C MRTFB HECW2 FGD5 LRRC36 IL7R	2.99e-08	193	157	9	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EXOC6 STIM2 ERC1 SH2D3C MRTFB HECW2 FGD5 LRRC36 IL7R	2.99e-08	193	157	9	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EXOC6 STIM2 ERC1 MRTFB HECW2 NAV3 FGD5 LRRC36 IL7R	2.99e-08	193	157	9	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	KCNH8 TMEM54 EXPH5 C10orf90 ARFGEF3 NTN4 LRRC36 CCSER1	4.56e-07	194	157	8	c011cd59bb4ca4134331cba0f5d73bdbd7011d64
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ASXL1 STIM2 KCNH8 RUBCNL BCL11A ZNF608 FCGR2B CCSER1	4.75e-07	195	157	8	0c49d22c348aec6d8a1a976e7c88d0a3b48a4244
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B SH2D3C MRTFB HECW2 FGD5 LRRC36 IL7R	4.78e-06	188	157	7	73f6ec915934154f435a376cb274b058ff7c5f35
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B SH2D3C MRTFB HECW2 FGD5 LRRC36 IL7R	5.49e-06	192	157	7	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	STIM2 SH2D3C MRTFB HECW2 FGD5 LRRC36 IL7R	5.49e-06	192	157	7	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	STIM2 SH2D3C MRTFB HECW2 FGD5 LRRC36 IL7R	5.49e-06	192	157	7	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EXOC6 SH2D3C MRTFB HECW2 FGD5 LRRC36 CCSER1	5.68e-06	193	157	7	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B IGHG2 CCSER1	5.68e-06	193	157	7	6e6c5ae39ea880ba809019a7d39f50e4e02007ed
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B IGHG2 CCSER1	5.68e-06	193	157	7	c04ac5884be4245b75d211046f04d76ae0cfb998
ToppCell	PBMC-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RUBCNL BCL11A ZNF608 FCGR2B IGHG2 IGHG4 CCSER1	5.87e-06	194	157	7	b6328575eedb19e0ad7f4d03041672f3dc146da0
ToppCell	PBMC-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	RUBCNL BCL11A ZNF608 FCGR2B IGHG2 IGHG4 CCSER1	5.87e-06	194	157	7	b16b96e42ea9734731342d4c41ff1711bd149462
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EXOC6 SH2D3C MRTFB ZNF608 HECW2 FGD5 IL7R	6.28e-06	196	157	7	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_activate-7\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RUBCNL ESPNL BCL11A ZNF608 FCGR2B CCSER1	6.55e-06	129	157	6	58790c6eaa597b8e8209a0fbc970e9cffa10bca5
ToppCell	Biopsy_Other_PF-Epithelial-SCGB3A2+\|Biopsy_Other_PF / Sample group, Lineage and Cell type	TMEM54 EXPH5 BPIFB1 C16orf89 ARFGEF3 IGHG4 MUC20	7.16e-06	200	157	7	631550dc34bcb605ab726645f4024d7828bb7975
ToppCell	mild_COVID-19_(asymptomatic)-B_intermediate\|World / disease group, cell group and cell class (v2)	RUBCNL ESPNL BCL11A FCGR2B IGHG2 IGHG4	2.23e-05	160	157	6	6722934e153b72039c3c4308557d0ef879a30638
ToppCell	VE-mono3\|VE / Condition, Cell_class and T cell subcluster	CTTNBP2 DSCAM CBARP KANK2 ALPK3 NAV3	2.31e-05	161	157	6	7df3fefc55ab43b897fc78d1f0c7383b10ac33d5
ToppCell	VE-mono3-\|VE / Condition, Cell_class and T cell subcluster	CTTNBP2 DSCAM CBARP KANK2 ALPK3 NAV3	2.31e-05	161	157	6	4e45bf7eceb0ee30dec4d8852778366776ea5a8f
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UPK3BL2 INSYN2A FCGR2B CAMSAP1 ESPL1 PPP6R2	2.40e-05	162	157	6	b502d6af6868425b5c919740e011330c0d3cf3b8
ToppCell	Healthy_Control-Lymphoid-Plasma\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	MYO18A PASK L3MBTL1 IGHG2 IGHG4 CCSER1	2.48e-05	163	157	6	2913ccdd4613472cd82077d4993e1d9f8b223398
ToppCell	Healthy_Control-Lymphoid-Plasma-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	MYO18A PASK L3MBTL1 IGHG2 IGHG4 CCSER1	2.48e-05	163	157	6	b589ff57d58dcb215ee3b5a10d81f43e5752a196
ToppCell	368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|368C / Donor, Lineage, Cell class and subclass (all cells)	DCHS2 AVPR2 EXPH5 SH2D3C PASK HECW2	2.75e-05	166	157	6	30a991fc3275b571d53bd0976df4789e5d40b01d
ToppCell	368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	DCHS2 AVPR2 EXPH5 SH2D3C PASK HECW2	2.75e-05	166	157	6	76b4cd32698900797ec009f17e50ea7ae36b85f4
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNH8 ESPNL BCL11A FCGR2B IGHG2 IGHG4	3.14e-05	170	157	6	ee2ee67d90ae4596de8ccd620e37c82cf51651d4
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNH8 ESPNL BCL11A FCGR2B IGHG2 IGHG4	3.14e-05	170	157	6	d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNH8 ESPNL BCL11A FCGR2B IGHG2 IGHG4	3.14e-05	170	157	6	52787f6d529c285d9f0c04cc022710ead5b89b3f
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROCK2 MYO18A HKDC1 ERBIN ANKIB1 PRLR	3.46e-05	173	157	6	e1378201b15ffb98e196ac39fe3ee4b4078953bd
ToppCell	facs-Large_Intestine-Proximal-3m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROCK2 MYO18A HKDC1 ERBIN ANKIB1 PRLR	3.46e-05	173	157	6	99532bb768ee35fed939a377acb5215d3f8904bd
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SHBG ARFGEF3 GOLGA8A PRLR TRPT1 MUC20	3.69e-05	175	157	6	dbd9dac129fb6ae5f55e7b96d04b37585458dc4a
ToppCell	normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells\|normal_Lymph_Node / Location, Cell class and cell subclass	MYO18A BCL11A INSYN2A PIK3R4 LRRC36 PHLPP2	3.69e-05	175	157	6	29fbdfe1d3bfcb063be2bced0128a33176c5b78f
ToppCell	normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells\|B_lymphocytes / Location, Cell class and cell subclass	MYO18A HKDC1 GFI1 INSYN2A PIK3R4 LRRC36	3.81e-05	176	157	6	d6e660df92a3d7dd5732171ee623763faf108476
ToppCell	IIH-mDC1-\|IIH / Condition, Cell_class and T cell subcluster	MYLK RUBCNL BCL11A ZNF608 C7 CCSER1	3.81e-05	176	157	6	bb80a3e595d071f6cc8b042984b8d9490e377eef
ToppCell	IIH-mDC1\|IIH / Condition, Cell_class and T cell subcluster	MYLK RUBCNL BCL11A ZNF608 C7 CCSER1	3.81e-05	176	157	6	a75dc132a1061006fd1cb305bd314784fca07ea6
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	BPIFB1 ZBTB34 L3MBTL1 MUC20 CCSER1	4.05e-05	108	157	5	9c7f3e25facfb54ef0be45044999bc36438bbea0
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	BPIFB1 ZBTB34 L3MBTL1 MUC20 CCSER1	4.05e-05	108	157	5	75d635fc5bb004418db2e1328c24d96b718f10b1
ToppCell	facs-Lung-Endomucin-24m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRFN1 MCPH1 C1orf162 TEP1 PASK NTAN1	4.19e-05	179	157	6	e520eadde4f1b7fb868dbbe94c4d62b3776c55eb
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-B_memory-0\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNH8 RUBCNL BCL11A FCGR2B IGHG2 CCSER1	4.19e-05	179	157	6	fce1ba53815145f6248d4e90aedca3dad84e33e4
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B SH2D3C HECW2 FGD5 LRRC36 IL7R	4.32e-05	180	157	6	30cf3c7ee29694eaccb89bf8053a82037d5c9f1d
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROCK2 TEP1 ERBIN CEP350 ZNF608 SCAF11	4.60e-05	182	157	6	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DCHS2 KCNH8 RUBCNL BCL11A FCGR2B CCSER1	4.74e-05	183	157	6	f4f453692da77cef666cc281c4883c9c6b279fd4
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DCHS2 KCNH8 RUBCNL BCL11A FCGR2B CCSER1	4.74e-05	183	157	6	6086a862ab35bc683af44c03ee14cbb08ab99945
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROCK2 ERBIN CEP350 ZNF608 SCAF11 IL7R	4.88e-05	184	157	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Memory_B_cells\|bone_marrow / Manually curated celltypes from each tissue	KCNH8 RUBCNL ESPNL BCL11A FCGR2B IGHG4	4.88e-05	184	157	6	ffc9eec123de34a4f17ed27fe4f0a1b3cb84697f
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	KCNH8 EXPH5 C10orf90 NTN4 LRRC36 CCSER1	5.19e-05	186	157	6	bb0bfe9a015151be08a6ffc5d82896d0556d76de
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	STIM2 SH2D3C MRTFB HECW2 FGD5 IL7R	5.34e-05	187	157	6	f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	STIM2 KCNH8 RUBCNL BCL11A ZNF608 CCSER1	5.50e-05	188	157	6	d8decd9b5967873ca8320c2f9f07365f163c777f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RUBCNL BCL11A ZNF608 FCGR2B IGHG2 CCSER1	5.50e-05	188	157	6	5707786cc4452dc34f95db2b3cd29f6e025c0622
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	KCNH8 TMEM54 EXPH5 ARFGEF3 ESPL1 LRRC36	5.67e-05	189	157	6	c8b8f860aaf6c73863cd79941db6b469c830ef06
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B CCSER1	5.83e-05	190	157	6	112706d64ee73b55dcf76f33ca064ab1fc6ce87f
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Naive_B_cells\|bone_marrow / Manually curated celltypes from each tissue	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B CCSER1	5.83e-05	190	157	6	3d45d5011305f13634013d9eeb98f235517dd54e
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SH2D3C MRTFB ZNF608 HECW2 FGD5 LRRC36	5.83e-05	190	157	6	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B SH2D3C HECW2 FGD5 LRRC36 IL7R	5.83e-05	190	157	6	a3c6eec6df052105ab78b7e3c78f94218d5912eb
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_naive\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B CCSER1	5.83e-05	190	157	6	e63945fa1dcd58bee129f1dd0c23b64a76241554
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_naive-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B CCSER1	5.83e-05	190	157	6	fa65bc5a178ae0c80a9bd4b282e4539493128a64
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B SH2D3C HECW2 FGD5 LRRC36 IL7R	5.83e-05	190	157	6	106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_activate-7\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B CCSER1	6.01e-05	191	157	6	2feab42ac6d29fa4eac78f3f78a5f8aa0a559523
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B IGHG2	6.01e-05	191	157	6	a831e30f37aff329d83fac9bdb84f783075d5df6
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B CCSER1	6.01e-05	191	157	6	8dda37ebf74b587129795f61541cc511ec97a314
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B IGHG2	6.01e-05	191	157	6	2453064c39b359088d43d52792bf829f83442c82
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KCNH8 EXPH5 MTMR7 ESPL1 LRRC36 CCSER1	6.18e-05	192	157	6	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	STIM2 KCNH8 RUBCNL BCL11A ZNF608 CCSER1	6.18e-05	192	157	6	446c61c0d6ba89c619efe87ee495951299953981
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	EXPH5 BPIFB1 C16orf89 ARFGEF3 NTN4 ZNF608	6.18e-05	192	157	6	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	EXPH5 C10orf90 C16orf89 NTN4 LRRC36 CCSER1	6.18e-05	192	157	6	39804d9ddc67c1b41887752df2503389eae44a1a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KCNH8 TMEM54 EXPH5 MTMR7 LRRC36 CCSER1	6.18e-05	192	157	6	d3634574b2e8d2ded6446969361b70761b331aea
ToppCell	Healthy-B_naive\|Healthy / disease group, cell group and cell class	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B IGHG2	6.18e-05	192	157	6	5fddf679dcc9c0077d6bfe04c1e602863fb959eb
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RUBCNL BCL11A FCGR2B IGHG2 IGHG4 CCSER1	6.18e-05	192	157	6	89b8ebdc285ed3c0f807fd1157271130d37dfa41
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KCNH8 TMEM54 EXPH5 MTMR7 LRRC36 CCSER1	6.18e-05	192	157	6	1aa5e4d9b32013a3f272561dcb8377f6805706df
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KCNH8 RUBCNL BCL11A FCGR2B IGHG2 IGHG4	6.18e-05	192	157	6	e33579a20ca86dcaf02c97273681ba5eee7561b8
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBIN ITGB5 CEP350 NAV3 SCAF11 IL7R	6.36e-05	193	157	6	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ASXL1 STIM2 KCNH8 RUBCNL BCL11A CCSER1	6.36e-05	193	157	6	bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBIN ITGB5 CEP350 NAV3 SCAF11 IL7R	6.36e-05	193	157	6	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B SH2D3C MRTFB HECW2 FGD5 LRRC36	6.36e-05	193	157	6	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EXOC6 MRTFB ZNF608 HECW2 FGD5 CCSER1	6.36e-05	193	157	6	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBIN ITGB5 CEP350 NAV3 SCAF11 IL7R	6.36e-05	193	157	6	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B SH2D3C MRTFB HECW2 FGD5 LRRC36	6.36e-05	193	157	6	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	ASK440-Epithelial-Secretory\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	EXPH5 RHOBTB3 BPIFB1 ZNF608 GOLGA8A PLXNB1	6.36e-05	193	157	6	50e98d91697c7af6a3de39e52edde6dd2b67b512
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RUBCNL BCL11A ZNF608 FCGR2B IGHG2 IGHG4	6.36e-05	193	157	6	89831e1007944e47719e58f23bfef5f1944cae23
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RUBCNL BCL11A FCGR2B IGHG2 IGHG4 CCSER1	6.36e-05	193	157	6	749faa5c592ee354733f5a7363a4277ef3462b93
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBIN ITGB5 CEP350 NAV3 SCAF11 IL7R	6.36e-05	193	157	6	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	KCNH8 EXPH5 ARFGEF3 MTMR7 LRRC36 CCSER1	6.55e-05	194	157	6	c5ef4ff73b4e51530656002e3a2fb7264cdf533d
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B CCSER1	6.55e-05	194	157	6	82753b90ca3b563275c41b6040ebbcd99b185e24
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B CCSER1	6.55e-05	194	157	6	83554ba6a789750a39af58537fd7044ce20d3f02
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B CCSER1	6.55e-05	194	157	6	56286db641cfb270e52f33989b8bf7b14d45010a
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B SH2D3C MRTFB HECW2 FGD5 IL7R	6.55e-05	194	157	6	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RUBCNL BCL11A ANKRD13A FCGR2B IGHG2 IGHG4	6.55e-05	194	157	6	cbc4b6422777117e4123804168c23f19d1b79486
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERC1 MRTFB ZNF608 HECW2 FGD5 CCSER1	6.55e-05	194	157	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	COVID-19_Severe-B_naive\|World / disease group, cell group and cell class	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B CCSER1	6.55e-05	194	157	6	d363963a6caeedf4f9e9ad22dcf9b66b85c79a48
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B SH2D3C MRTFB HECW2 FGD5 IL7R	6.55e-05	194	157	6	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	10x5'-Liver-Myeloid_Dendritic\|Liver / Manually curated celltypes from each tissue	RUBCNL BCL11A C1orf162 FCGR2A FCGR2B CCSER1	6.55e-05	194	157	6	e6391bc7073831847c469ef0b0c437118e1f151f
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KCNH8 EXPH5 ARFGEF3 MTMR7 LRRC36 CCSER1	6.55e-05	194	157	6	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B CCSER1	6.74e-05	195	157	6	9355dd84350f98cb33466acdfd90a39c50c9e39f
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TMEM54 EXPH5 C10orf90 C16orf89 LRRC36 CCSER1	6.74e-05	195	157	6	98dd3b7d5ef587825dac052dea4d4ff883f6d4d6
ToppCell	PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	EXPH5 C10orf90 C16orf89 NTN4 LRRC36 CCSER1	6.74e-05	195	157	6	f08e41706680881ebd0afcd08a02f8ac0089f04e
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	EXPH5 C10orf90 C16orf89 NTN4 LRRC36 CCSER1	6.74e-05	195	157	6	62d369a8af2b76a2553bc8ff9cb89a133b060123
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B CCSER1	6.74e-05	195	157	6	8f5a664dd65c38afe23c6acd0a9c22ba4fd347ed
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	KCNH8 RUBCNL BCL11A ZNF608 FCGR2B CCSER1	6.74e-05	195	157	6	e830f0c545be87a1056a4505bdf6845e5ac7750d
ToppCell	background-Endothelial_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	CTTNBP2 NTN4 FCGR2B HECW2 C7 CCSER1	6.74e-05	195	157	6	c7d60dabfc7cb310e002cab10003dadfcc34fe33
ToppCell	PCW_10-12-Epithelial\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	KCNH8 EXPH5 ARFGEF3 NTN4 LRRC36 CCSER1	6.93e-05	196	157	6	9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2
Drug	Loestrin	SHBG FCGR2C FCGR2A FCGR2B FSHB	2.39e-07	21	153	5	CID000062925
Drug	MDL 20,610	FCGR2C FCGR2A FCGR2B	2.95e-06	5	153	3	CID000128209
Drug	AC1L9LSE	FCGR2C FCGR2A FCGR2B HPS4	3.35e-06	16	153	4	CID000448272
Drug	TAN-1030A	FCGR2C FCGR2A FCGR2B	5.86e-06	6	153	3	CID009576886
Drug	Kaempferol [520-18-3]; Down 200; 14uM; MCF7; HT_HG-U133A	ROCK2 CDC42EP4 CEP350 CEP68 ZNF335 TTLL4 TOPORS PLXNB1 IL27RA	6.82e-06	194	153	9	7196_DN
Drug	Adrenosterone [382-45-6]; Down 200; 13.4uM; HL60; HT_HG-U133A	CDC42EP4 MCPH1 EXPH5 NUMA1 FAAP100 RUSC2 PASK SF3B3 FAM149B1	8.04e-06	198	153	9	3107_DN
Drug	AC1MHTIN	FCGR2C FCGR2A FCGR2B	1.02e-05	7	153	3	CID003011133
Drug	Ak 295	CAPN2 CAPNS1 CAST	1.02e-05	7	153	3	CID000183798
Drug	TAN-999	FCGR2C FCGR2A FCGR2B	1.02e-05	7	153	3	CID000130283
Drug	Intravenous Immunoglobulin	FCGR2C FCGR2A FCGR2B	1.63e-05	8	153	3	DB00028
Drug	AC1NSK5W	FCGR2C FCGR2A FCGR2B	2.43e-05	9	153	3	CID005311182
Drug	Parthenolide [20554-84-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	PASK MRTFB SF3B3 FBXO5 TTLL4 ESPL1 TOP3A PHTF1	3.43e-05	183	153	8	5530_DN
Drug	Palivizumab	FCGR2C FCGR2A FCGR2B	3.45e-05	10	153	3	DB00110
Drug	Denny-Jaffe reagent	FCGR2C FCGR2A FCGR2B	3.45e-05	10	153	3	CID003035979
Drug	Z-leu-met-h	CAPNS1 CAST	4.49e-05	2	153	2	CID003082865
Drug	Bevacizumab	FCGR2C FCGR2A FCGR2B	4.72e-05	11	153	3	DB00112
Drug	Tositumomab	FCGR2C FCGR2A FCGR2B	4.72e-05	11	153	3	DB00081
Drug	Alemtuzumab	FCGR2C FCGR2A FCGR2B	4.72e-05	11	153	3	DB00087
Drug	Efalizumab	FCGR2C FCGR2A FCGR2B	4.72e-05	11	153	3	DB00095
Drug	Alefacept	FCGR2C FCGR2A FCGR2B	4.72e-05	11	153	3	DB00092
Drug	Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; HL60; HT_HG-U133A	CDC42EP4 CAPN2 FAAP100 RUSC2 ZNF335 PRR14L FAM149B1 TOP3A	5.00e-05	193	153	8	1873_DN
Drug	Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A	CEP68 PASK BRF1 ZNF335 FAM149B1 BRD1 TOPORS IL27RA	5.19e-05	194	153	8	7221_DN
Drug	Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A	PRKD2 ERC1 UNC5B FAAP100 RUSC2 CEP350 PPP6R2 TOP3A	5.78e-05	197	153	8	3314_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	CDC42EP4 ADGRL1 BRF1 ZNF335 TTLL4 FAM149B1 PRLR IL27RA	5.99e-05	198	153	8	7177_DN
Drug	Flecainide acetate [54143-56-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	ROCK2 NUMA1 ADGRL1 BCL11A ITGB5 PASK CSRNP3 QSER1	5.99e-05	198	153	8	3761_DN
Drug	Repaglinide [135062-02-1]; Up 200; 8.8uM; PC3; HT_HG-U133A	ROCK2 RHOBTB3 DUSP7 LMTK2 PASK HPS4 TTLL4 QSER1	5.99e-05	198	153	8	5862_UP
Drug	Daclizumab	FCGR2C FCGR2A FCGR2B	6.26e-05	12	153	3	DB00111
Drug	Natalizumab	FCGR2C FCGR2A FCGR2B	6.26e-05	12	153	3	DB00108
Drug	Rituximab	FCGR2C FCGR2A FCGR2B	6.26e-05	12	153	3	DB00073
Drug	Ibritumomab	FCGR2C FCGR2A FCGR2B	6.26e-05	12	153	3	DB00078
Drug	Adalimumab	FCGR2C FCGR2A FCGR2B	6.26e-05	12	153	3	DB00051
Drug	Gemtuzumab ozogamicin	FCGR2C FCGR2A FCGR2B	6.26e-05	12	153	3	DB00056
Drug	Cetuximab	FCGR2C FCGR2A FCGR2B	6.26e-05	12	153	3	DB00002
Drug	SNJ-1945	CAPN2 CAPNS1 CAST	6.26e-05	12	153	3	CID006857712
Drug	Haloperidol [52-86-8]; Down 200; 10.6uM; HL60; HG-U133A	ROCK2 PRKD2 ASXL1 SZT2 SF3B3 NTAN1 HTT IL27RA	6.43e-05	200	153	8	2039_DN
Drug	NSC9564	CAPN2 CAPNS1 SHBG CAST FSHB	7.66e-05	65	153	5	CID000004536
Drug	AC1L1ET5	PRKD2 CAPN2 CAPNS1 CAST HTT	7.66e-05	65	153	5	CID000002936
Drug	Trastuzumab	FCGR2C FCGR2A FCGR2B	8.10e-05	13	153	3	DB00072
Drug	Basiliximab	FCGR2C FCGR2A FCGR2B	8.10e-05	13	153	3	DB00074
Drug	p-MeC	CAPN2 CAPNS1 CAST	1.03e-04	14	153	3	CID000451929
Drug	Abciximab	FCGR2C FCGR2A FCGR2B	1.03e-04	14	153	3	DB00054
Drug	Etanercept	FCGR2C FCGR2A FCGR2B	1.03e-04	14	153	3	DB00005
Drug	AC1NFF1B	AVPR2 CAPNS1 CAST	1.03e-04	14	153	3	CID004657542
Drug	X 49	CAPN2 CAPNS1 CAST	1.03e-04	14	153	3	CID000407235
Drug	Muromonab	FCGR2C FCGR2A FCGR2B	1.28e-04	15	153	3	DB00075
Drug	AC1NRA23	TMEM54 BEAN1 CAPN2 CAPNS1 CAST	1.33e-04	73	153	5	CID005287657
Drug	Ak 275	CAPN2 CAPNS1	1.34e-04	3	153	2	CID000133051
Drug	tyrphostin 23	ROCK2 PRKD2 MYLK FCGR2C FCGR2A FCGR2B	1.35e-04	116	153	6	CID000002052
Drug	Thimerosal	EXOC6 PRKD2 STIM2 MCPH1 ERC1 RHOBTB3 DUSP7 AGBL5 RUSC2 CEP350 ARFGEF3 FSHB NAV3 PRR14L FRMPD3 GOLGA8A PRLR TP53BP1 IL27RA CCSER1	1.60e-04	1199	153	20	ctd:D013849
Drug	Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; HL60; HT_HG-U133A	RHOBTB3 DUSP7 BCL11A KANK2 CEP68 PASK IL27RA	1.67e-04	172	153	7	2195_DN
Disease	SYSTEMIC LUPUS ERYTHEMATOSUS	TREX1 FCGR2A FCGR2B	2.65e-06	6	152	3	152700
Disease	malaria (implicated_via_orthology)	FCGR2C FCGR2A FCGR2B	1.10e-05	9	152	3	DOID:12365 (implicated_via_orthology)
Disease	plexin-B2 measurement	FCGR2C FCGR2B PPP6R2	1.10e-05	9	152	3	EFO_0021867
Disease	Systemic lupus erythematosus	TREX1 FCGR2A FCGR2B	2.15e-05	11	152	3	cv:C0024141
Disease	immunoglobulin G measurement	IGHG2 IGHG4	2.64e-05	2	152	2	EFO_0020465
Disease	seropositivity measurement, Chlamydia pneumoniae seropositivity	NUMA1 L3MBTL1	7.88e-05	3	152	2	EFO_0007034, EFO_0007035
Disease	interleukin-18-binding protein measurement	XNDC1N NUMA1	7.88e-05	3	152	2	EFO_0020495
Disease	low affinity immunoglobulin gamma Fc region receptor II-a measurement	FCGR2C FCGR2A FCGR2B	8.64e-05	17	152	3	EFO_0021969
Disease	obesity (implicated_via_orthology)	DCHS2 STIM2 ADAMTS4 CAPN2 TSC1 GORASP1 PLXNB1	1.31e-04	215	152	7	DOID:9970 (implicated_via_orthology)
Disease	low affinity immunoglobulin gamma Fc region receptor II-b measurement	FCGR2C FCGR2A FCGR2B	2.84e-04	25	152	3	EFO_0021970
Disease	systemic lupus erythematosus (is_implicated_in)	TREX1 CAST FCGR2A FCGR2B	2.99e-04	62	152	4	DOID:9074 (is_implicated_in)
Disease	low affinity immunoglobulin gamma Fc region receptor II-a/b measurement	FCGR2A FCGR2B	5.44e-04	7	152	2	EFO_0008211
Disease	BPI fold-containing family B member 1 measurement	BPIFB1 BPIFA2	5.44e-04	7	152	2	EFO_0801429
Disease	lymphoid leukemia (is_implicated_in)	FCGR2A FCGR2B	5.44e-04	7	152	2	DOID:1037 (is_implicated_in)
Disease	cortical surface area measurement	ROCK2 EXOC6 PRKD2 DCHS2 CTTNBP2 MCPH1 CAPN2 CRPPA AGBL5 ITGB5 NTN4 EXOC6B NAV3 HINT3 QSER1 BRD1 PRLR	5.89e-04	1345	152	17	EFO_0010736
Disease	serum non-albumin protein measurement	EXOC6 ADAMTS4 NUMA1 SHBG FCGR2C BRF1 FCGR2A FCGR2B	5.91e-04	361	152	8	EFO_0004568
Disease	Large cell carcinoma of lung	LMTK2 ALPK3 MYO18B	5.96e-04	32	152	3	C0345958
Disease	interleukin 27 receptor subunit alpha measurement	BRME1 IL27RA	7.23e-04	8	152	2	EFO_0008183
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	CRPPA NTAN1 ZNF335 KDF1 TP53BP1 HTT	1.06e-03	222	152	6	EFO_0008317, EFO_0020943
Disease	carpal tunnel syndrome	CRPPA KANK2 ITGB5 ZBTB34	1.18e-03	89	152	4	EFO_0004143
Disease	systemic lupus erythematosus (implicated_via_orthology)	FCGR2C FCGR2A FCGR2B	1.42e-03	43	152	3	DOID:9074 (implicated_via_orthology)
Disease	hereditary spastic paraplegia (implicated_via_orthology)	ATP5MC2 CAPN2 RTN3	1.42e-03	43	152	3	DOID:2476 (implicated_via_orthology)
Disease	basophil percentage of leukocytes	SH2D3C FCGR2C FCGR2A FCGR2B IL7R PHTF1	1.67e-03	243	152	6	EFO_0007992
Disease	Adenoid Cystic Carcinoma	BCL11A ERBIN BRD1 ESPL1	1.81e-03	100	152	4	C0010606
Disease	fetal genotype effect measurement, body weights and measures	CRPPA FCGR2B FGD5	2.08e-03	49	152	3	EFO_0004324, EFO_0007959
Disease	sitting height ratio	PRKD2 CRPPA C10orf90	2.33e-03	51	152	3	EFO_0007118
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	CRPPA NTAN1 ZNF335 KDF1 TP53BP1 HTT	2.53e-03	264	152	6	EFO_0008317, EFO_0020944
Disease	autoimmune thrombocytopenic purpura (is_implicated_in)	FCGR2A FCGR2B	2.65e-03	15	152	2	DOID:8924 (is_implicated_in)
Disease	Autosomal recessive primary microcephaly	MCPH1 ZNF335	2.65e-03	15	152	2	cv:C3711387
Disease	response to tenofovir, creatinine clearance measurement	EXOC6 C10orf90 FGD5 C7	2.73e-03	112	152	4	EFO_0007934, EFO_0009279
Disease	Metastatic melanoma	ROCK2 PASK ALPK3	2.74e-03	54	152	3	C0278883
Disease	Malaria, susceptibility to	FCGR2A FCGR2B	3.02e-03	16	152	2	cv:C1970028
Disease	–	FCGR2A FCGR2B	3.02e-03	16	152	2	611162
Disease	Libman-Sacks Disease	TREX1 FCGR2A FCGR2B	3.36e-03	58	152	3	C0242380
Disease	SLAM family member 7 measurement	ADAMTS4 C7	3.41e-03	17	152	2	EFO_0008287
Disease	Malaria	FCGR2A FCGR2B	4.71e-03	20	152	2	C0024530

Protein segments in the cluster

Peptide	Gene	Start	Entry
SCRSTSLSGPEEAGS	UPK3BL1	231	B0FP48
ESSELELGSCSATPG	AGBL5	816	Q8NDL9
IHECDSGEASSATTP	CBARP	181	Q8N350
TEPHDSDCSVDLGIS	ERBIN	836	Q96RT1
SRSTCGDSEVEEESP	BRD1	801	O95696
TDSSEPCGLSDLCRS	C16orf89	171	Q6UX73
GLSCRSERSAVDPSS	CFAP97	501	Q9P2B7
SASGPTRLVLSDCAT	BPIFB1	146	Q8TDL5
SLPRTTTICSGHDAD	CEP68	136	Q76N32
LDVCLDTSSSGLDLP	ALG1L2	146	C9J202
SESCTAEDGATSRPL	ADGRL1	1361	O94910
DSVTLTCQGARSPES	FCGR2A	56	P12318
SVTLTCRGTHSPESD	FCGR2B	66	P31994
SASTDFCLSPEVLSG	ALPK3	1556	Q96L96
ISLSPGDLDTSLCDI	ANKIB1	321	Q9P2G1
LTDESLSSLAVSCPL	ATP5MC2	36	Q06055
ASPSCSVDVTERAGS	CCSER1	226	Q9C0I3
SERTKDTPLSLACSG	ANKRD17	1146	O75179
TCLSEISNSTRASPE	CCDC140	96	Q96MF4
ASCEVDPSSGDSISL	CAMSAP1	481	Q5T5Y3
DDASGRSSPCLSTAS	CAMSAP1	786	Q5T5Y3
ILTDSGSAPTFCSDD	FAM193A	281	P78312
LHPDVRTECESGTTS	ASXL1	781	Q8IXJ9
SEPLSFEEGLSSSCE	ASXL3	2081	Q9C0F0
SSRTGEPCVAELTEE	ERC1	251	Q8IUD2
SPSCLGDSLAETTLS	RUBCNL	91	Q9H714
ETTRQSSLSCSPIGD	QSER1	226	Q2KHR3
LTTSESEVEPAACLA	INSYN2A	11	Q6ZSG2
LVSTVVSPSADGCLD	CRPPA	186	A4D126
TEGLCPSALSETSRF	ANKRD13A	536	Q8IZ07
SEASTRPEGESDLEC	HECW2	626	Q9P2P5
ASDSGISCEEVPSEA	ESPNL	711	Q6ZVH7
CATSELRETPSSLAV	PASK	761	Q96RG2
GLLDSEDSRLSCSPC	KRT40	391	Q6A162
GTPCASDIRSSSLTL	MYLK	1336	Q15746
ELTASEASTRSPLCE	HSFY1	16	Q96LI6
SSREEEGPSTSCILE	MAGEA1	81	P43355
EGRATSSCVTSAPEE	MCPH1	491	Q8NEM0
SPDSCEGSVCERSSE	GFI1	71	Q99684
TGSDPREAIFDTLCT	MUC20	131	Q8N307
SDQESGVEDLSCRSP	MTMR7	621	Q9Y216
SATSLCLLPSEETSG	LRFN1	646	Q9P244
CLLPSEETSGEESRA	LRFN1	651	Q9P244
GLAPDCEASATAETT	HINT3	11	Q9NQE9
SADGISSRLTPAESC	HPS4	521	Q9NQG7
TPEDDDCLSTSSRGI	BCL11A	106	Q9H165
EVDGSSPCSSVRESD	CSRNP3	11	Q8WYN3
SVTLTCRGTHSPESD	FCGR2C	66	P31995
ATVSTGPVLDSRDCL	PLXNB1	66	O43157
IDLTGTSLCSLPEDN	KIAA0232	481	Q92628
CGDLLTSLSNPDSST	LRRC36	376	Q1X8D7
SATLGLPSSALDVSC	L3MBTL1	26	Q9Y468
SLLCTVAASDPDTGD	PCDHGC5	471	Q9Y5F6
VSSSSELDLPSGDHC	MYO18A	1066	Q92614
HCSSRPLELTETESS	NAV3	36	Q8IVL0
SCSPLSESAKGLESE	FGD5	361	Q6ZNL6
SIKDEASLPDCSSSR	MRTFB	626	Q9ULH7
CLDSASAPRSVAVSS	IL27RA	316	Q6UWB1
SVRLGTSESLPCTAE	PRKD2	206	Q9BZL6
TSESLPCTAEELSRS	PRKD2	211	Q9BZL6
PCTAEELSRSTTELL	PRKD2	216	Q9BZL6
CSRSESPSDSEGEEI	MYCLP1	151	P12525
ISPVESDSSVRDCSL	EXPH5	1161	Q8NEV8
NSVSSCTDRSLSPDL	LHX5	131	Q9H2C1
ETQDDRPCTLASTGT	LMTK2	1216	Q8IWU2
ITPESFGRDSSLTCL	IL7R	356	P16871
CSSRSDLPGSDKDTE	SLC9A3R2	271	Q15599
ESTDTACIGPTLRSV	EXOC6B	26	Q9Y2D4
STPSDLCVVDLSRGS	FAAP100	361	Q0VG06
DSDSTDCTVRGLGPS	FSHB	106	P01225
TASFEVSLEARSCPS	ITGB5	421	P18084
RAQSESLSDLTCTPE	CRACDL	246	Q6NV74
IESTDTACVGPTLRS	EXOC6	21	Q8TAG9
SGPEDICSSSSSHER	GORASP1	341	Q9BQQ3
PRDSDQLSCLSGETD	DCHS2	3136	Q6V1P9
EPSSSESRTGLCSPE	FAM171A2	731	A8MVW0
ESRTGLCSPEDNSLT	FAM171A2	736	A8MVW0
RSSECLDGTLTPSDG	MON1A	106	Q86VX9
SSPSEDSCLLELQGS	FAM189B	341	P81408
PTTADHLTCLLSSGD	DPYSL4	311	O14531
TEDCPTGSALTFREE	ADAMTS4	571	O75173
PVATGLSTLDSICDS	ESPL1	1566	Q14674
PLSASDESRKSCTVG	HTT	1051	P42858
AVSSSPDEETGSPCR	BRME1	66	Q0VDD7
LGECASDPTSISLSL	BPIFA2	171	Q96DR5
VSASSCRPGASDSLL	CTTNBP2	671	Q8WZ74
RPSDSCKEESSTLSV	FBXO5	31	Q9UKT4
TRATCTDSCTSPILD	FRMPD2B	201	Q6IN97
RSDPESGVSCLTTCA	FRMPD3	1396	Q5JV73
LCDLAGPSSTESESR	ARFGEF3	376	Q5TH69
FDTDRSGTICSSELP	CAPNS1	181	P04632
TLTGRDSCTLPASAE	C7	756	P10643
SSCTSGILEERSPAF	CDC42EP4	311	Q9H3Q1
EEQSPSISGCFLSSE	CEP350	2806	Q5VT06
CSDGESDRELPSSAT	DUSP7	216	Q16829
IDALSGDLDSCPSTT	CAST	651	P20810
ASEARSTASECPSLL	IFRD2	101	Q12894
CPSLLSTTAEDSLGG	IFRD2	111	Q12894
SCDISLTDRDGSTAL	KANK2	796	Q63ZY3
EAATLSCTLTSDLGP	IGFN1	471	Q86VF2
LAPCSRSTSESTAAL	IGHG2	11	P01859
LAPCSRSTSESTAAL	IGHG4	11	P01861
HCLSEGSDSSLEEPS	GPATCH2	86	Q9NW75
LDTSSLVPGCSSVDN	POLR2M	106	P0CAP2
LTDSCPTLDGTSDSG	BEAN1	171	Q3B7T3
SLLGCSIDITSAADS	CAPN2	236	P17655
STCKPDTERQGTLST	C1orf162	6	Q8NEQ5
GSSSSESCAQDLPVL	SCAF11	471	Q99590
EDSQLDPGCSRSSSR	C3orf56	216	Q8N813
SPVDTECSHAEGSRS	PPP6R2	771	O75170
NEGPVSSSSSDCRET	PPP4R2	366	Q9NY27
EVSCFTSDLSGPESR	PRR14L	341	Q5THK1
SIDSLDLSCEEGTPL	NUMA1	1721	Q14980
PLCTSDRGSCVSTTE	RHOBTB3	146	O94955
AVTRPDSESSCVLSE	FAM149B1	306	Q96BN6
DSLTSSTPSESGICR	DSCAM	1856	O60469
TEGDRTSPCAVSSAT	GOLGA8A	16	A7E2F4
LSSCSDLSPDESPVS	RUSC1	106	Q9BVN2
CLSPDGSSEAISIDL	RUSC2	976	Q8N2Y8
QEGLSSLCSDEPSSE	RTN3	66	O95197
LCTEDTPTGSLRNGS	SZT2	2396	Q5T011
ESGSGSREAPTSCES	SZT2	2881	Q5T011
SCRSTSLSGPEEAGS	UPK3BL2	231	E5RIL1
SLIQLAGPSSDTCES	SPATA31C2	681	B4DYI2
PSCDVRFLLSESGST	HKDC1	436	Q2TB90
DPITGDCISSHTDID	NTN4	456	Q9HB63
DRSYSTPSGCLELTD	NBPF20	1486	P0DPF2
DRSYSTPSGCLELTD	NBPF20	2706	P0DPF2
ISASAPTSLRSCDVE	SHBG	206	P04278
VRGCSPCLSTEDSTE	KDF1	106	Q8NAX2
DGSISILGSDDATTC	NTAN1	61	Q96AB6
PLSLAGDEETECQSS	TRPT1	226	Q86TN4
IPTGADSCVTSLSCD	RPTOR	1161	Q8N122
GLLSRSPVCSCESAS	SLX4IP	266	Q5VYV7
LDSLCSGASAEEPTS	CIAO3	296	Q9H6Q4
IGDSSPSDDCLSRDL	C10orf90	451	Q96M02
VSCLETSSSASPARD	C17orf64	21	Q86WR6
RSESSAGICVPLSTS	PIK3R4	891	Q99570
STATPECTARGASLE	SLC49A3	486	Q6UXD7
GDSDDSCDTVILSPT	SPRYD3	341	Q8NCJ5
PAGDRECQTSLETSI	TSC1	566	Q92574
VEGRDLLSCTSSEPL	TMEM54	206	Q969K7
ADDTCIPRSSAAVTA	TEP1	2271	Q99973
TPGTDPSTCRESDAS	TEP1	2516	Q99973
LESLPSACTGEESLS	PHLPP2	606	Q6ZVD8
LLHGPECRSSVTSDS	PHTF1	386	Q9UMS5
DACSLLGLSVESPLS	RMND5B	271	Q96G75
PDTASECDSLNSSIG	STIM2	591	Q9P246
DTDSGRGSCDSPSLL	PRLR	346	P16471
LLSDSPSCRETDSIQ	ROCK2	421	O75116
DPVDSSNLDTCGSIS	TP53BP1	91	Q12888
TTLAETPAGSLDTLC	UNC5B	826	Q8IZJ1
GTTPTLSCSLLGDDA	SF3B3	501	Q15393
PTAASLGISDSIREC	BRF1	416	Q92994
LPDSVLEASRDSSVC	TOP3A	691	Q13472
TQFSSCESLLESRPS	MYO18B	2346	Q8IUG5
CSSLDSLDDSVVGPS	XNDC1N	151	Q6ZNB5
DSDVSRCSSPHSVLG	TOPORS	526	Q9NS56
GLSNVALECSEPSTS	ZNF608	601	Q9ULD9
LTADKVTRSDGCPTS	SH2D3C	366	Q8N5H7
RILVSSCSSGESIEP	MID2	56	Q9UJV3
EEGDSECSSLSAVSP	TTLL4	531	Q14679
LADGPTSTSTCLEAQ	ZNF335	196	Q9H4Z2
SSEAPSLLCSDTLGG	ZNF335	761	Q9H4Z2
ACSPAASEITGLSTA	TREX1	76	Q9NSU2
LGPQDESCTTASSSL	AVPR2	351	P30518
SDRPSCSDSSSLGDD	ZBTB34	241	Q8NCN2
VDSESPSSGREGTSC	ZBTB8B	156	Q8NAP8
RDSTCSDTSPPAREE	KCNC4	516	Q03721
EEEAVSLSPICTRGS	KCNH8	721	Q96L42
EASLDSCPESSVGAV	NACAD	1146	O15069
SCPESSVGAVSSLDR	NACAD	1151	O15069